The Bumpy Road to Brexit
What will a Brexit mean for the OTC derivatives industry in London? We investigate.
Commentary
Brexit and OTC Clearing – A Look at the Possible Impact
A discussion of‘Bremir’ and how a Brexit may impact euro denominated central clearing.
SA-CCR – Understanding the Methodology and Implications
Arthur Rabatin, of Deutsche Bank, offers a brief introduction to the new BCBS standardized approach for measuring counterparty risk (SA-CCR) and explores some of the implications of adopting this methodology.
ESMA Consults on Proposed Central Clearing Delay for Small Financial Counterparties
The European Securities and Markets Authority (ESMA) has published today a consultation paper proposing to change the phase-in…
Brexit No Need For Panic – Yet
The industry asserts not much will change immediately as a result of Brexit however, the long-term view is full of uncertainty.
EMIR OTC Clearing: What’s Next?
In a DerivSource webinar, a panel explores the steps needed to prepare for EMIR OTC clearing and new market developments aiming to support buy-side firms, and corporates mid-tier banks join the clearing space successfully.
The European Swaps Market – Futurisation Next?
In a commentary article, Eurex Clearing’s Byron Baldwin explores if futurisation will take hold of the European…
SA-CCR and FRTB: Why a Regulatory Calculation Engine Should Be Part of the Plan
Why is a regulatory calculation engine is essential for compliance with BCBS’s new market and credit counterparty risk requirements?
Unique Identifiers for Derivatives – Finding the Middle Ground
The debate on global identifiers for OTC derivatives – we explore.
Are You Ready for SA-CCR? (Infographic)
An infographic explores how some market firms are preparing to comply with BCBS’ SA-CCR.